Mesh.i
Exploration
Accueil
Racine
Exploration
Accueil
Racine

La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « Mesh.i » - entrée « In Vitro Techniques »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
In Situ Nick-End Labeling < In Vitro Techniques < Inactivation, Metabolic  Facettes :

List of bibliographic references indexed by In Vitro Techniques

Number of relevant bibliographic references: 17.
Ident.Authors (with country if any)Title
000846 (2015) Lina A. Matschke [Allemagne] ; Mirjam Bertoune [Allemagne] ; Jochen Roeper [Allemagne] ; Terrance P. Snutch [Canada] ; Wolfgang H. Oertel [Allemagne] ; Susanne Rinné [Allemagne] ; Niels Decher [Allemagne]A concerted action of L- and T-type Ca(2+) channels regulates locus coeruleus pacemaking.
000933 (2014) Sherri L. Thiele [Canada] ; Betty Chen [Canada] ; Charlotte Lo [Canada] ; Tracey S. Gertler [États-Unis] ; Ruth Warre [Canada] ; James D. Surmeier [États-Unis] ; Jonathan M. Brotchie [Canada] ; Joanne E. Nash [Canada]Selective loss of bi-directional synaptic plasticity in the direct and indirect striatal output pathways accompanies generation of parkinsonism and l-DOPA induced dyskinesia in mouse models
001185 (2012) Omid Tavassoly [Canada] ; Jeremy S. LeeMethamphetamine binds to α-synuclein and causes a conformational change which can be detected by nanopore analysis.
001202 (2012) Dali Zhang [Canada] ; Wei Xiong ; Stephanie Chu ; Chao Sun ; Benedict C. Albensi ; Fiona E. ParkinsonInhibition of hippocampal synaptic activity by ATP, hypoxia or oxygen-glucose deprivation does not require CD73.
001674 (2011) Dali Zhang [Canada] ; Wei Xiong ; Benedict C. Albensi ; Fiona E. ParkinsonExpression of human equilibrative nucleoside transporter 1 in mouse neurons regulates adenosine levels in physiological and hypoxic-ischemic conditions.
001A45 (2010) Joseph P. Steiner [États-Unis] ; Kathryn B. Payne ; Christopher Drummond Main ; Sabrina D'Alfonso ; Kirsten X. Jacobsen ; T Philip Hicks ; William A. Staines ; Michael O. PoulterGPI-1046 increases presenilin-1 expression and restores NMDA channel activity.
001A51 (2010) Qingjia Meng [Canada] ; Dirk W. Luchtman ; Bouchaib El Bahh ; Jeffrey A. Zidichouski ; Jun Yang ; Cai SongEthyl-eicosapentaenoate modulates changes in neurochemistry and brain lipids induced by parkinsonian neurotoxin 1-methyl-4-phenylpyridinium in mouse brain slices.
001D59 (2009) Robert J. Parkinson [Canada] ; Jack P. CallaghanThe role of dynamic flexion in spine injury is altered by increasing dynamic load magnitude.
002358 (2008) M. Quinn [Canada] ; K. Mukhida [Canada] ; D. Sadi [Canada] ; M. Hong [Canada] ; I. MendezAdjunctive use of the non‐ionic surfactant Poloxamer  188 improves fetal dopaminergic cell survival and reinnervation in a neural transplantation strategy for Parkinson's disease
002982 (2005) Robert J. Parkinson [Canada] ; Jennifer L. Durkin ; Jack P. CallaghanEstimating the compressive strength of the porcine cervical spine: an examination of the utility of DXA.
003109 (2001) C. Zhang [Canada] ; J P Steiner ; G S Hamilton ; T P Hicks ; M O PoulterRegeneration of dopaminergic function in 6-hydroxydopamine-lesioned rats by neuroimmunophilin ligand treatment.
004124 (1994) A. Qi [Canada] ; C R Kerr ; J A Yeung-Lai-WahElectrophysiologic properties of a narrow isthmus in rabbit atrial tissue: cycle length dependent effect of quinidine.
004392 (1993) Philip Seeman [Canada] ; Hong-Chang Guan [Canada] ; Hubert H. M. Van Tol [Canada] ; Hyman B. Niznik [Canada]Low density of dopamine D4 receptors in Parkinson's, schizophrenia, and control brain striata
004503 (1992) M. P. Rathbone [Canada] ; S. Deforge [Canada] ; B. Deluca [Canada] ; B. Gabel [Canada] ; C. Laurenssen [Canada] ; P. Middlemiss [Canada] ; S. Parkinson [Canada]Purinergic stimulation of cell division and differentiation: Mechanisms and pharmacological implications
004680 (1991) F E Parkinson [Canada] ; A S ClanachanAdenosine receptors and nucleoside transport sites in cardiac cells.
004A17 (1989) F E Parkinson [Canada] ; A S ClanachanHeterogeneity of nucleoside transport inhibitory sites in heart: a quantitative autoradiographical analysis.
004A42 (1989) Fiona E. Parkinson [Canada] ; Alexander S. Clanachan [Canada]Subtypes of nucleoside transport inhibitory sites in heart: a quantitative autoradiographical analysis

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "In Vitro Techniques" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "In Vitro Techniques" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    In Vitro Techniques
}}
Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022